Who we are
CellCircuit Bio is a biotechnology service company (CRO) advancing cellular immunofluorescence and immunocytochemistry (ICC/IF) through high-quality staining, imaging, and quantitative analysis.
Founded by Stanford-affiliated scientists, CellCircuit Bio supports biopharma, biotech companies, antibody developers, and academic research teams with reliable, reproducible immunofluorescence data across 2D and 3D cell models, including complex and translational biological systems.
We integrate optimized ICC/IF workflows, advanced fluorescence imaging, computational image analysis, and nano- and microengineered systems to enable precise visualization and quantification of protein expression, subcellular localization, and cellular signaling states.
Backed by a scientific team with extensive hands-on experience in cellular imaging, assay development, and bioengineered systems, we also provide scientific guidance and technical advisory support, helping clients refine experimental design, select appropriate markers and assays, and interpret results with confidence.
Leadership team
Bio
Dr. Sadegh Ghorbani is a multidisciplinary scientist and biotech entrepreneur with over a decade of experience spanning cellular biology, tissue engineering, nanoscience, biomaterials engineering, and translational research. His work focuses on the development of biologically relevant in vitro models and the generation of high-quality, decision-ready data from complex cellular systems.
Dr. Ghorbani has extensive hands-on expertise in immunocytochemistry and immunofluorescence (ICC/IF), advanced fluorescence microscopy, and quantitative image analysis, working across 2D monolayers, engineered 3D microenvironments, spheroids, and organoids. His scientific background includes the design of protein- and biomaterial-based cellular microenvironments, with a strong emphasis on how biochemical and biomechanical signaling cues at nano- and microscale regulate cell fate, morphology, and function. His research has contributed to advanced disease modeling, microphysiological systems, and translational tissue engineering platforms. He has co-authored over 30 peer-reviewed research articles in leading journals, including Nature Communications, Biomaterials, Small Methods, and Biofabrication, reflecting sustained contributions to the field of cell and tissue engineering.
In parallel with his scientific career, Dr. Ghorbani has been actively involved in biotech venture creation, intellectual property strategy, and technology commercialization. He previously co-founded and served as CEO of Geneazma, a biotech CRO focused on 3D bioscaffold fabrication and stem cell-based platforms for tissue engineering and regenerative medicine. At Geneazma, he led custom R&D programs for academic and clinical partners, directed prototype development and cross-disciplinary collaborations, and oversaw business operations, client engagement, and early commercialization strategy.
Dr. Ghorbani conducted research at Stanford University, where his work advanced the development of engineered complex in vitro models for translational applications. He holds a Ph.D. in Nanoscience (Nano-Bioengineering) from Aarhus University (iNANO), Denmark.
Through CellCircuit Bio, Dr. Ghorbani combines scientific rigor with operational execution, delivering advanced ICC/IF services, imaging-driven assay development, and scientific consulting for biopharma, biotech companies, antibody developers, and research teams. His work bridges advanced cell modeling, imaging technologies, and applied biotechnology, enabling partners to extract meaningful insight from complex biological systems.
Bio
Betty Cai is an experienced researcher in biomaterials engineering, particularly in the fields of tissue engineering and 3D bioprinting. She is a PhD candidate in Materials Science and Engineering at Stanford University, where she has co-authored over 10 research articles in leading journals such as Science, Nature Communications, Advanced Functional Materials, Advanced Science, and Biofabrication. Additionally, she brings a multidisciplinary perspective from her previous experience as a materials science researcher at AbbVie and Apple.
Betty has extensive experience in ICC/IF, fluorescence microscopy, and quantitative image analysis for cell-laden hydrogels and 3D bioprinted structures. Leveraging 10 years of academic training in materials science, she has expertise in designing hydrogel formulations for improved biological performance and high-quality cellular characterization results. Furthermore, Betty is a skilled communicator across academic, industry, and entrepreneurial contexts. At CellCircuit Bio, she aims to leverage her interdisciplinary background to support research teams in obtaining high-quality scientific results and communicating their work in the most impactful way.
Bio
Yee Lin Tan is a biomaterials engineer and translational researcher with over nine years of research experience. She is currently an MS/PhD candidate in Materials Science and Engineering at Stanford University, where she focuses on advanced 3D printing technologies for biofabrication and engineered tissue systems.
She previously earned her BEng in Materials Science and Engineering from Imperial College London UK. Yee Lin has authored over 10 peer-reviewed publications in leading journals, including Science Advances and ACS Nano, reflecting her expertise in translational bioengineering.
Beyond the lab, she brings strategic experience in healthcare and deep tech, having led consulting efforts on market and translational analyses within R&D institutes for biomolecular engineering and AI-enabled digital health technologies. At the intersection of biomaterials innovation and commercialization, she is committed to delivering rigorous, decision-ready imaging insights that accelerate biotech development.
CellCircuit Biotechnologies
Transforming Precision Cellular Analysis
Platform Development
In parallel with our CRO services, we are developing a patent-pending automation platform originating from Stanford research, designed to bring scalability and reproducibility to immunofluorescence-based assays.
Contact us
hello@cellcircuitbio.com
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!